Status:
TERMINATED
Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
Lead Sponsor:
Masonic Cancer Center, University of Minnesota
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
RATIONALE: Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving internal radiation therapy using a special radiation therapy device may kill an...
Detailed Description
OBJECTIVES: Primary * Determine the ipsilateral breast tumor recurrence rate in women with ductal carcinoma in situ undergoing lumpectomy followed by brachytherapy using the MammoSite\^® Radiation T...
Eligibility Criteria
Inclusion
- Ductal carcinoma in situ (DCIS) confirmed by excisional or needle biopsy
- Size: \< 3 cm on mammogram
- Unicentric disease
- Ability to place MammoSite device at time of lumpectomy or within 4 weeks of lumpectomy
- Patient Age: ≥ 18 years, no upper limit
- Life expectancy \> 5 years
Exclusion
- Prior history of cancer other than basal or squamous cell skin cancer or in situ cancer of the cervix
- Pregnant or breast feeding
- Multicentric disease
- Diagnosis of collagen vascular diseases, such as systemic lupus erythematosis, scleroderma, or dermatomyositis
Key Trial Info
Start Date :
December 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00290654
Start Date
December 1 2002
End Date
March 1 2013
Last Update
December 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States, 55455